| Literature DB >> 35898163 |
Xinyi Hua1, Jingjing Yin1, Isaac C H Fung1.
Abstract
OBJECTIVES: To estimate the rate ratio (RR) of reported Coronavirus Disease 2019 (COVID-19) cases among governmental employees from seven District of Columbia (D.C.) departments from March 2020 to February 2022.Entities:
Keywords: COVID-19; District of Columbia; SARS-CoV-2; emergency responders; occupational health
Year: 2022 PMID: 35898163 PMCID: PMC9384596 DOI: 10.1093/annweh/wxac049
Source DB: PubMed Journal: Ann Work Expo Health ISSN: 2398-7308 Impact factor: 2.779
Figure 1.The RR (cross) and 95% CIs (bar) of COVID-19 case rates for seven D.C. departments for five selected time intervals: 7 March 2020–14 December 2020, 15 December 2020–1 July 2021, 2 July 2021–2 November 2021, 3 November 2021–28 February 2022, and 7 March 2020–28 February 2022. The departments analyzed were: FEMS, MPD, DOC, DYRS, the OUC, the CFSA, and DMV.
The RR of COVID-19 cases of seven D.C. departments, from 7 March 2020 to 28 February 2022. Dates are displayed as month/day/year.,,,,,,
| Departments | 3/7/2020–12/14/2020 | 12/15/2020–7/1/2021 | 7/2/2021–11/2/2021 | 11/3/2021–2/28/2022 | 3/7/2020–2/28/2022 (overall) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | |
| FEMS | 3.34 | (2.94, 3.77) | 2.39 | (2.06, 2.75) | 2.48 | (2.06, 2.95) | 3.90 | (3.56, 4.26) | 3.07 | (2.91, 3.25) |
| MPD | 2.33 | (2.11, 2.58) | 1.96 | (1.75, 2.18) | 1.52 | (1.29, 1.77) | 1.76 | (1.60, 1.92) | 1.98 | (1.89, 2.07) |
| DOC | 2.88 | (2.41, 3.41) | 1.75 | (1.30, 2.16) | 1.10 | (0.77, 1.52) | 3.19 | (2.81, 3.61) | 2.53 | (2.34, 2.73) |
| Youth Rehabilitation Services | 1.93 | (1.39, 2.60) | 1.86 | (1.32, 2.52) | 0.71 | (0.34, 1.28) | 1.73 | (1.32, 2.23) | 1.62 | (1.39, 1.87) |
| OUC | 1.47 | (0.92, 2.18) | 2.72 | (1.93, 3.69) | 1.85 | (1.09, 2.92) | 2.18 | (1.62, 2.85) | 2.15 | (1.84, 2.50) |
| CFSA | 0.62 | (0.38, 0.96) | 1.41 | (1.02, 1.89) | 0.76 | (0.43, 1.23) | 0.74 | (0.55, 1.02) | 0.99 | (0.85, 1.16) |
| DMV | 1.76 | (1.04, 2.78) | 1.72 | (1.01, 2.70) | 0.51 | (0.13, 1.31) | 1.00 | (0.89, 1.12) | 0.79 | (0.57, 1.06) |
Residents of D.C. were used as the reference group.
The first COVID-19 case in D.C. was reported on 7 March 2020.
The first dose of the Pfizer-BioNTech COVID-19 vaccination was administered in the USA on 15 December 2020.
Fifty percent of the D.C. residents were considered fully vaccinated on 1 July 2021 (Centers for Disease Control and Prevention, 2022c).
The Delta variant became dominant in the USA on 7 July 2021 (Crist, 2021; Lovelace, 2021).
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices made an interim recommendation to use the Pfizer-BioNTech COVID-19 vaccine in teens aged 12–15 years on 12 May 2021, and in children aged 5–11 years on 2 November 2021.
The first cases of Omicron variant in D.C. were announced on 13 December 2021 (Trujillo, 2021).